Data as of May 23
| +0.19 / +6.35%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 17.50, with a high estimate of 17.50 and a low estimate of 17.50. The median estimate represents a +450.31% increase from the last price of 3.18.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.